Screener
Amylyx Pharmaceuticals, Inc. AMLX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accounts payable | 2,014 | 338 |
| Accrued expenses | (3,494) | (6,484) |
| Operating lease liabilities | (702) | (1,158) |
| Net cash used in operating activities | (68,306) | (65,072) |
| Cash flows used in investing activities: | ||
| Purchases of property and equipment | (30) | (28) |
| Milestone payments related to IPR&D | (4,000) | — |
| Purchases of investments | (200,505) | (142,637) |
Item 1. Financial Statements.
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s operating cash flow?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported operating cash flow of -$31.42M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s operating cash flow decreased by 24.5% year-over-year, from -$25.25M to -$31.42M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s operating cash flow has grown at a 13.3% compound annual growth rate (CAGR), from -$74.8M to -$123.34M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude